marketcaparena
Search

    DNA

    Ginkgo Bioworks Holdings, Inc.

    Company overview

    Market capitalization
    —
    Employees
    485
    Latest publication
    2026-09-29
    About Ginkgo Bioworks Holdings, Inc.

    Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops a platform for cell engineering in the United States. It operates through the Cell Engineering and Biosecurity segments. The company offers cell engineering research and development solutions, as well as cell engineering tools comprising functional genomics, antibody developability, and small molecule developability, artificial intelligence models, and reconfigurable automation cart systems on its platform for use in the research, development, and commercialization of engineered organisms and derived products. It also provides biomonitoring and bioinformatics support services through Canopy, which generates genomic data from strategically positioned nodes through biomonitoring programs; and Horizon, a digital surveillance, analytics, and insights platform that detects and monitors biothreats. In addition, the company offers genetic medicine R&D, protein engineering, bioprocess development, crop nutrition and protection solutions, and plant trait optimization. The company serves pharmaceutical and biotechnology, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ4 20252025-12-31 · USDQ2 20202020-06-30 · USDQ1 20202020-03-31 · USD
    Total Revenue33,396,000USD10,163,000USD21,134,000USD
    Cost Of Revenue-8,150,000USD——
    Gross Profit41,546,000USD10,163,000USD21,134,000USD
    Research Development50,127,000USD32,270,000USD30,236,000USD
    Selling General Administrative46,014,000USD8,949,000USD6,568,000USD
    Unclassified Operating Expenses16,157,000USD——
    Total Operating Expenses112,298,000USD41,219,000USD36,804,000USD
    Operating Income-70,752,000USD-31,056,000USD-15,670,000USD
    Interest Income4,710,000USD——
    Net Interest Income4,710,000USD——
    Income Before Tax-81,394,000USD-28,724,000USD-23,599,000USD
    Income Tax Expense-643,000USD6,000USD1,869,000USD
    Tax Provision-643,000USD——
    Net Income-80,751,000USD-28,658,000USD-24,972,000USD
    Net Income From Continuing Ops-80,751,000USD——
    Ebit-81,394,000USD-31,056,000USD-15,670,000USD
    Ebitda-34,869,000USD-27,877,000USD-12,516,000USD
    Depreciation And Amortization46,525,000USD3,179,000USD3,154,000USD
    Reconciled Depreciation13,663,000USD——
    Total Other Income Expense Net-10,642,000USD2,332,000USD-7,929,000USD
    Net Income Applicable To Common Shares-80,751,000USD-28,658,000USD-24,972,000USD
    Minority Interest—7,467,000USD7,467,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20192019-12-31 · USD
    Total Revenue54,184,000USD
    Cost Of Revenue0USD
    Gross Profit54,184,000USD
    Research Development96,299,000USD
    Selling General Administrative29,483,000USD
    Total Operating Expenses125,782,000USD
    Operating Income-71,598,000USD
    Interest Income5,756,000USD
    Interest Expense2,421,000USD
    Net Interest Income3,335,000USD
    Income Before Tax-119,835,000USD
    Income Tax Expense22,000USD
    Tax Provision22,000USD
    Net Income-119,327,000USD
    Net Income From Continuing Ops-119,857,000USD
    Ebit-117,414,000USD
    Ebitda-106,659,000USD
    Depreciation And Amortization10,755,000USD
    Reconciled Depreciation10,755,000USD
    Total Other Income Expense Net-48,237,000USD
    Minority Interest8,790,000USD
    Net Income Applicable To Common Shares-119,327,000USD
    SourceLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Total Assets1,033,075,000USD1,119,696,000USD1,189,165,000USD1,231,009,000USD1,293,463,000USD1,377,449,000USD1,480,883,000USD1,625,255,000USD
    Intangible Assets48,860,000USD56,924,000USD61,522,000USD66,152,000USD68,756,000USD72,510,000USD79,566,000USD90,602,000USD
    Other Current Assets16,684,000USD25,192,000USD22,790,000USD26,208,000USD20,442,000USD18,729,000USD22,324,000USD34,104,000USD
    Total Liab589,922,000USD611,106,000USD629,382,000USD618,057,000USD646,036,000USD661,391,000USD682,940,000USD792,183,000USD
    Total Stockholder Equity443,153,000USD508,590,000USD559,783,000USD612,952,000USD647,427,000USD716,058,000USD797,943,000USD833,072,000USD
    Other Current Liab48,376,000USD42,618,000USD79,341,000USD57,231,000USD70,747,000USD33,533,000USD75,833,000USD117,118,000USD
    Common Stock6,000USD6,000USD6,000USD6,000USD5,000USD5,000USD5,000USD206,000USD
    Capital Stock6,000USD6,000USD6,000USD6,000USD5,000USD5,000USD5,000USD206,000USD
    Retained Earnings-6,232,907,000USD-6,150,320,000USD-6,069,569,000USD-5,988,814,000USD-5,928,514,000USD-5,837,557,000USD-5,730,023,000USD-5,673,620,000USD
    Cash143,864,000USD167,202,000USD111,065,000USD203,566,000USD312,420,000USD561,572,000USD616,214,000USD730,367,000USD
    Cash And Short Term Investments373,456,000USD422,620,000USD461,862,000USD473,691,000USD516,922,000USD561,572,000USD616,214,000USD730,367,000USD
    Total Current Assets409,955,000USD471,838,000USD506,082,000USD523,025,000USD564,534,000USD602,744,000USD662,480,000USD783,362,000USD
    Total Current Liabilities79,595,000USD95,970,000USD115,281,000USD96,720,000USD115,667,000USD107,266,000USD114,427,000USD166,154,000USD
    Current Deferred Revenue14,910,000USD19,979,000USD25,236,000USD28,287,000USD33,653,000USD30,599,000USD22,894,000USD26,007,000USD
    Net Debt266,836,000USD272,683,000USD311,805,000USD225,261,000USD122,141,000USD-93,841,000USD-170,622,000USD-278,102,000USD
    Short Long Term Debt Total410,700,000USD439,885,000USD422,870,000USD428,827,000USD434,561,000USD467,731,000USD445,592,000USD452,265,000USD
    Long Term Investments14,599,000USD14,875,000USD29,891,000USD32,446,000USD31,962,000USD48,466,000USD61,850,000USD62,235,000USD
    Short Term Investments229,592,000USD255,418,000USD350,797,000USD270,125,000USD204,502,000USD0USD—57,796,000USD
    Net Receivables19,815,000USD24,026,000USD21,430,000USD23,126,000USD27,170,000USD22,443,000USD23,942,000USD18,891,000USD
    Accounts Payable16,309,000USD10,566,000USD10,704,000USD11,202,000USD11,267,000USD14,169,000USD15,700,000USD23,029,000USD
    Property Plant Equipment Net516,824,000USD528,701,000USD544,792,000USD562,150,000USD581,222,000USD598,155,000USD616,946,000USD628,590,000USD
    Property Plant Equipment Gross706,200,000USD719,298,000USD726,867,000USD735,645,000USD744,643,000USD759,027,000USD767,681,000USD764,816,000USD
    Accumulated Other Comprehensive Income1,194,000USD1,851,000USD1,996,000USD1,653,000USD-850,000USD-1,806,000USD263,000USD-1,723,000USD
    Common Stock Shares Outstanding59,563,454shares55,457,676shares55,633,718shares54,858,982shares54,241,619shares51,894,639shares52,246,000shares51,375,600shares
    Non Current Assets Total623,120,000USD647,858,000USD683,083,000USD707,984,000USD728,929,000USD774,705,000USD818,403,000USD841,893,000USD
    Non Current Liabilities Total510,327,000USD515,136,000USD514,101,000USD521,337,000USD530,369,000USD554,125,000USD568,513,000USD626,029,000USD
    Non Current Liabilities Other21,732,000USD22,876,000USD17,159,000USD17,944,000USD15,430,000USD16,576,000USD17,674,000USD20,895,000USD
    Non Currrent Assets Other42,733,000USD47,167,000USD46,594,000USD47,236,000USD46,989,000USD55,574,000USD60,041,000USD60,211,000USD
    Net Working Capital330,360,000USD375,868,000USD390,801,000USD426,305,000USD448,867,000USD495,478,000USD548,053,000USD617,208,000USD
    Unclassified Non Current Liabilities488,595,000USD492,260,000USD496,942,000USD503,393,000USD514,939,000USD537,549,000USD550,839,000USD605,134,000USD
    Unclassified Equity6,674,854,000USD6,657,047,000USD6,627,344,000USD6,600,101,000USD6,576,781,000USD6,555,411,000USD6,527,693,000USD6,508,003,000USD
    Other Assets—47,167,000USD46,594,000USD47,020,000USD46,778,000USD41,166,000USD45,180,000USD—
    Cash And Equivalents—167,202,000USD111,065,000USD203,566,000USD312,420,000USD561,572,000USD616,214,000USD—
    Short Term Debt—22,807,000USD0USD0USD0USD28,965,000USD0USD—
    Unclassified Non Current Assets—-46,976,000USD-46,310,000USD-47,020,000USD-46,778,000USD-41,166,000USD-45,180,000USD—
    Good Will—————0USD0USD0USD
    Unclassified Current Assets———————-57,796,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USD
    Total Assets1,119,696,000USD1,377,449,000USD1,665,342,000USD2,539,321,000USD2,070,990,000USD675,153,000USD697,318,000USD
    Intangible Assets56,924,000USD72,510,000USD82,741,000USD111,041,000USD21,642,000USD3,294,000USD3,843,000USD
    Other Current Assets25,192,000USD18,729,000USD39,731,000USD45,897,000USD19,780,000USD14,563,000USD8,960,000USD
    Total Liab611,106,000USD661,391,000USD568,190,000USD803,044,000USD503,611,000USD205,101,000USD195,465,000USD
    Total Stockholder Equity508,590,000USD716,058,000USD1,097,152,000USD1,736,277,000USD1,505,365,000USD461,376,000USD493,063,000USD
    Other Current Liab42,618,000USD33,533,000USD88,568,000USD85,362,000USD92,585,000USD58,843,000USD37,037,000USD
    Common Stock6,000USD5,000USD5,000USD190,000USD161,000USD129,000USD79,000USD
    Capital Stock6,000USD5,000USD199,000USD190,000USD161,000USD129,000USD—
    Retained Earnings-6,150,320,000USD-5,837,557,000USD-5,290,528,000USD-4,397,659,000USD-2,297,925,000USD-467,878,000USD-341,269,000USD
    Other Assets47,167,000USD41,166,000USD42,224,000USD88,725,000USD43,990,000USD18,901,000USD9,308,000USD
    Cash167,202,000USD561,572,000USD944,073,000USD1,315,792,000USD1,550,004,000USD380,801,000USD495,287,000USD
    Cash And Equivalents167,202,000USD561,572,000USD944,073,000USD1,315,792,000USD1,550,004,000USD380,801,000USD495,287,000USD
    Cash And Short Term Investments422,620,000USD561,572,000USD944,073,000USD1,315,792,000USD1,550,004,000USD380,801,000USD495,287,000USD
    Total Current Assets471,838,000USD602,744,000USD1,001,749,000USD1,450,079,000USD1,723,045,000USD426,542,000USD511,925,000USD
    Total Current Liabilities95,970,000USD107,266,000USD163,860,000USD172,962,000USD134,761,000USD73,221,000USD40,074,000USD
    Current Deferred Revenue19,979,000USD30,599,000USD48,495,000USD47,817,000USD33,240,000USD28,823,000USD—
    Net Debt272,683,000USD-93,841,000USD-704,764,000USD-873,204,000USD-1,526,974,000USD-363,798,000USD-477,922,000USD
    Short Term Debt22,807,000USD28,965,000USD17,474,000USD29,332,000USD747,000USD485,000USD598,000USD
    Short Long Term Debt Total439,885,000USD467,731,000USD239,309,000USD442,588,000USD23,030,000USD17,003,000USD17,365,000USD
    Long Term Investments14,875,000USD48,466,000USD77,911,000USD113,731,000USD102,037,000USD103,124,000USD—
    Short Term Investments255,418,000USD0USD-654,000USD————
    Net Receivables24,026,000USD22,443,000USD17,899,000USD84,026,000USD149,899,000USD21,906,000USD7,678,000USD
    Accounts Payable10,566,000USD14,169,000USD9,323,000USD10,451,000USD8,189,000USD13,893,000USD2,439,000USD
    Property Plant Equipment Net528,701,000USD598,155,000USD394,994,000USD718,791,000USD145,770,000USD121,435,000USD63,132,000USD
    Property Plant Equipment Gross719,298,000USD759,027,000USD517,942,000USD715,535,000USD206,822,000USD155,213,000USD—
    Accumulated Other Comprehensive Income1,851,000USD-1,806,000USD1,484,000USD-2,632,000USD-1,715,000USD0USD—
    Common Stock Shares Outstanding55,457,676shares51,894,639shares48,610,500shares41,995,975shares34,009,325shares31,869,173shares28,725,010shares
    Non Current Assets Total647,858,000USD774,705,000USD663,593,000USD1,089,242,000USD347,945,000USD248,611,000USD185,393,000USD
    Non Current Liabilities Total515,136,000USD554,125,000USD404,330,000USD630,082,000USD368,850,000USD131,880,000USD155,391,000USD
    Non Current Liabilities Other22,876,000USD16,576,000USD18,733,000USD31,191,000USD194,113,000USD3,032,000USD—
    Non Currrent Assets Other47,167,000USD55,336,000USD58,709,000USD87,406,000USD43,990,000USD18,901,000USD9,308,000USD
    Net Working Capital375,868,000USD495,478,000USD837,889,000USD1,277,117,000USD1,588,284,000USD353,321,000USD—
    Unclassified Non Current Assets-46,976,000USD-40,928,000USD-42,224,000USD-90,662,000USD-30,796,000USD-18,901,000USD97,945,000USD
    Unclassified Non Current Liabilities492,260,000USD537,549,000USD385,597,000USD207,298,000USD-346,567,000USD13,486,000USD16,767,000USD
    Unclassified Equity6,657,047,000USD6,555,411,000USD6,385,992,000USD6,136,188,000USD3,804,683,000USD928,996,000USD834,253,000USD
    Good Will—0USD49,238,000USD60,210,000USD21,312,000USD1,857,000USD1,857,000USD
    Inventory——46,000USD4,364,000USD3,362,000USD9,272,000USD0USD
    Deferred Long Term Liab———174,767,000USD174,737,000USD——
    Other Liab———216,826,000USD346,567,000USD115,362,000USD138,624,000USD
    Net Tangible Assets———1,565,026,000USD1,462,411,000USD456,041,000USD487,186,000USD
    Unclassified Current Liabilities—————-28,823,000USD—
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income-76,059,000USD-80,751,000USD-80,755,000USD-60,300,000USD-90,957,000USD-107,534,000USD-56,403,000USD-217,181,000USD
    Depreciation12,799,000USD13,663,000USD14,168,000USD15,793,000USD15,366,000USD15,652,000USD17,171,000USD17,330,000USD
    Stock Based Compensation15,853,000USD21,027,000USD17,841,000USD22,247,000USD20,431,000USD20,561,000USD13,855,000USD37,146,000USD
    Other Non Cash Items15,152,000USD23,334,000USD3,363,000USD4,719,000USD15,204,000USD26,707,000USD33,772,000USD72,435,000USD
    Change To Account Receivables-242,000USD-1,818,000USD757,000USD4,281,000USD-4,693,000USD1,376,000USD-4,999,000USD5,668,000USD
    Change In Working Capital-14,178,000USD-23,587,000USD13,777,000USD-22,713,000USD-11,565,000USD2,179,000USD-98,041,000USD5,880,000USD
    Total Cash From Operating Activities-46,433,000USD-47,678,000USD-31,606,000USD-40,254,000USD-51,521,000USD-42,435,000USD-103,501,000USD-84,390,000USD
    Capital Expenditures-1,933,000USD-15,325,000USD-7,660,000USD-38,000USD-7,622,000USD-13,710,000USD-15,089,000USD-27,032,000USD
    Free Cash Flow-48,366,000USD-63,003,000USD-31,606,000USD-40,292,000USD-59,143,000USD-56,145,000USD-118,590,000USD-111,422,000USD
    Investments25,017,000USD94,991,000USD-72,816,000USD-63,888,000USD-198,684,000USD-13,085,000USD-10,200,000USD-26,841,000USD
    Total Cashflows From Investing Activities23,132,000USD95,099,000USD-72,816,000USD-63,888,000USD-198,684,000USD-13,085,000USD-10,200,000USD-26,841,000USD
    Net Borrowings-19,000USD-25,000USD-24,000USD-98,000USD-207,000USD-203,000USD-200,000USD—
    Total Cash From Financing Activities-19,000USD8,141,999USD9,938,000USD-98,000USD-207,000USD-203,000USD-465,000USD-226,000USD
    Change In Cash-23,338,000USD54,364,000USD-94,391,000USD-105,848,000USD-250,338,000USD-55,796,000USD-113,651,000USD-111,048,000USD
    Begin Period Cash Flow167,202,000USD119,869,000USD251,351,000USD320,363,000USD605,743,000USD661,539,000USD732,720,000USD843,768,000USD
    End Period Cash Flow143,864,000USD174,233,000USD156,960,000USD214,515,000USD355,405,000USD605,743,000USD619,069,000USD732,720,000USD
    Other Cashflows From Investing Activities48,000USD-58,166,000USD249,000USD142,000USD120,000USD57,000USD538,000USD191,000USD
    Other Cashflows From Financing Activities-19,000USD-512,000USD9,962,000USD0USD0USD4,000USD-265,000USD-40,000USD
    Sale Purchase Of Stock—19,469,000USD10,317,000USD0USD0USD84,000USD84,000USD—
    Issuance Of Capital Stock—9,152,000USD——————
    Unclassified Operating Cash Flow—-1,364,000USD————-13,855,000USD—
    Unclassified Investing Cash Flow—73,599,000USD7,411,000USD—7,502,000USD13,653,000USD14,551,000USD26,841,000USD
    Unclassified Financing Cash Flow—-10,790,001USD-10,317,000USD—————
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USD
    Net Income-312,763,000USD-547,029,000USD-892,869,000USD-2,106,372,000USD-1,836,642,000USD-126,723,000USD-119,857,000USD
    Depreciation58,990,000USD63,020,000USD71,554,000USD42,552,000USD29,076,000USD13,864,000USD10,755,000USD
    Stock Based Compensation81,546,000USD112,344,000USD229,884,000USD1,930,641,000USD1,606,020,000USD476,000USD771,000USD
    Other Non Cash Items46,620,000USD142,686,000USD266,895,000USD-67,404,000USD-20,947,000USD3,068,000USD-1,642,000USD
    Change To Account Receivables-1,473,000USD-4,725,000USD50,068,000USD55,024,000USD-114,094,000USD-14,228,000USD-1,843,000USD
    Change In Working Capital-44,088,000USD-89,670,000USD29,837,000USD-37,006,000USD-61,537,000USD-26,515,000USD10,577,000USD
    Total Cash From Operating Activities-171,059,000USD-319,585,000USD-295,500,000USD-252,198,000USD-253,818,000USD-135,830,000USD-44,663,000USD
    Capital Expenditures-7,665,000USD-62,541,000USD-40,801,000USD-52,271,000USD-56,521,000USD-57,821,000USD-22,219,000USD
    Free Cash Flow-178,724,000USD-382,126,000USD-336,301,000USD-304,469,000USD-310,339,000USD-193,651,000USD-66,882,000USD
    Investments-233,248,000USD-62,236,000USD-4,279,000USD-67,394,000USD-5,000,000USD-67,121,000USD-50,133,000USD
    Total Cashflows From Investing Activities-240,289,000USD-62,236,000USD-80,693,000USD-67,394,000USD-73,257,000USD-67,121,000USD-74,602,000USD
    Net Borrowings-354,000USD-897,000USD-1,295,000USD97,836,000USD-1,123,000USD-748,000USD198,605,000USD
    Total Cash From Financing Activities17,775,000USD-1,739,000USD-3,216,000USD95,337,000USD1,534,145,000USD90,318,000USD410,385,000USD
    Sale Purchase Of Stock19,469,000USD84,000USD-23,000USD-24,998,000USD-24,998,000USD91,066,000USD-408,000USD
    Issuance Of Capital Stock19,469,000USD0USD0USD99,303,000USD0USD91,040,000USD212,181,000USD
    Change In Cash-393,178,000USD-383,841,000USD-379,997,000USD-223,347,000USD1,207,051,000USD-112,633,000USD291,120,000USD
    Begin Period Cash Flow567,411,000USD989,584,000USD1,369,581,000USD1,592,928,000USD385,877,000USD498,510,000USD207,390,000USD
    End Period Cash Flow174,233,000USD605,743,000USD989,584,000USD1,369,581,000USD1,592,928,000USD385,877,000USD498,510,000USD
    Other Cashflows From Investing Activities624,000USD1,186,000USD-1,340,000USD-38,078,000USD304,000USD-9,300,000USD-2,250,000USD
    Other Cashflows From Financing Activities-1,340,000USD-922,000USD-1,898,000USD-2,729,000USD1,560,266,000USD91,066,000USD212,188,000USD
    Unclassified Investing Cash Flow—61,355,000USD-34,273,000USD90,349,000USD-12,040,000USD67,121,000USD—
    Change To Inventory———164,000USD-626,000USD-2,736,000USD-2,222,000USD
    Change To Liabilities———-50,452,000USD-12,745,000USD-12,404,000USD5,547,000USD
    Dividends Paid———-981,000USD-1,509,796,000USD——
    Cash And Cash Equivalents Changes———-224,255,000USD1,207,070,000USD——
    Unclassified Operating Cash Flow———-14,609,000USD30,212,000USD—54,733,000USD
    Unclassified Financing Cash Flow———26,209,000USD1,509,796,000USD-91,066,000USD—
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    FY 2025Yearly · 2025-12-31ProductCell Engineering Revenue132,746,000USD0001628280-26-012346
    FY 2025Yearly · 2025-12-31ProductProduct0USD0001628280-26-012346
    FY 2025Yearly · 2025-12-31ProductServices37,409,000USD0001628280-26-012346
    Q3 2025Quarterly · 2025-09-30ProductBiosecurity9,457,000USD0001628280-25-050193
    Q3 2025Quarterly · 2025-09-30ProductCell Engineering29,380,000USD0001628280-25-050193
    Q3 2025Quarterly · 2025-09-30SegmentBiosecurity9,457,000USD0001628280-25-050193
    Q3 2025Quarterly · 2025-09-30SegmentCell Engineering29,380,000USD0001628280-25-050193
    Q2 2025Quarterly · 2025-06-30ProductCell Engineering Revenue39,134,000USD0001628280-25-038982
    Q2 2025Quarterly · 2025-06-30ProductServices10,470,000USD0001628280-25-038982
    Q2 2025Quarterly · 2025-06-30SegmentBiosecurity10,470,000USD0001628280-25-038982
    Q2 2025Quarterly · 2025-06-30SegmentCell Engineering39,134,000USD0001628280-25-038982
    Q1 2025Quarterly · 2025-03-31ProductCell Engineering Revenue38,230,000USD0001628280-25-022761
    Q1 2025Quarterly · 2025-03-31ProductServices10,088,000USD0001628280-25-022761
    Q1 2025Quarterly · 2025-03-31SegmentBiosecurity10,088,000USD0001628280-25-022761
    Q1 2025Quarterly · 2025-03-31SegmentCell Engineering38,230,000USD0001628280-25-022761
    FY 2024Yearly · 2024-12-31ProductCell Engineering Revenue173,972,000USD0001628280-26-012346
    FY 2024Yearly · 2024-12-31ProductProduct0USD0001628280-26-012346
    FY 2024Yearly · 2024-12-31ProductServices53,071,000USD0001628280-26-012346
    Q4 2024Quarterly · 2024-12-31ProductCell Engineering Revenue34,789,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductProduct0USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductServices9,058,000USDLegacy provider
    Q3 2024Quarterly · 2024-09-30ProductCell Engineering Revenue75,089,000USD0001628280-24-047284
    Q3 2024Quarterly · 2024-09-30ProductProduct0USD0001628280-24-047284
    Q3 2024Quarterly · 2024-09-30ProductServices13,957,000USD0001628280-24-047284
    Q3 2024Quarterly · 2024-09-30SegmentBiosecurity13,957,000USD0001628280-25-050193
    Q3 2024Quarterly · 2024-09-30SegmentCell Engineering75,089,000USD0001628280-25-050193
    Q2 2024Quarterly · 2024-06-30ProductCell Engineering Revenue36,205,000USD0001628280-24-036231
    Q2 2024Quarterly · 2024-06-30ProductProduct0USD0001628280-24-036231
    Q2 2024Quarterly · 2024-06-30ProductServices20,001,000USD0001628280-24-036231
    Q2 2024Quarterly · 2024-06-30SegmentBiosecurity20,001,000USD0001628280-25-038982
    Q2 2024Quarterly · 2024-06-30SegmentCell Engineering36,205,000USD0001628280-25-038982
    Q1 2024Quarterly · 2024-03-31ProductCell Engineering Revenue27,889,000USD0001628280-24-022229
    Q1 2024Quarterly · 2024-03-31ProductProduct0USD0001628280-24-022229
    Q1 2024Quarterly · 2024-03-31ProductServices10,055,000USD0001628280-24-022229
    Q1 2024Quarterly · 2024-03-31SegmentBiosecurity10,055,000USD0001628280-25-022761
    Q1 2024Quarterly · 2024-03-31SegmentCell Engineering27,889,000USD0001628280-25-022761
    FY 2023Yearly · 2023-12-31ProductCell Engineering Revenue143,531,000USD0001628280-26-012346
    FY 2023Yearly · 2023-12-31ProductProduct28,949,000USD0001628280-26-012346
    FY 2023Yearly · 2023-12-31ProductServices78,975,000USD0001628280-26-012346
    Q4 2023Quarterly · 2023-12-31ProductCell Engineering Revenue26,976,000USDLegacy provider
    Q4 2023Quarterly · 2023-12-31ProductProduct0USDLegacy provider
    Q4 2023Quarterly · 2023-12-31ProductServices7,779,000USDLegacy provider
    Q4 2023Quarterly · 2023-12-31SegmentBiosecurity7,779,000USDLegacy provider
    Q4 2023Quarterly · 2023-12-31SegmentCell Engineering26,976,000USDLegacy provider
    FY 2023Yearly · 2023-12-31SegmentBiosecurity107,924,000USD0001628280-24-008052
    FY 2023Yearly · 2023-12-31SegmentCell Engineering143,531,000USD0001628280-24-008052
    Q3 2023Quarterly · 2023-09-30SegmentBiosecurity18,254,000USD0001628280-24-047284
    Q3 2023Quarterly · 2023-09-30SegmentCell Engineering37,176,000USD0001628280-24-047284
    FY 2022Yearly · 2022-12-31ProductCell Engineering Revenue143,666,000USD0001628280-25-007819
    FY 2022Yearly · 2022-12-31ProductProduct35,455,000USD0001628280-25-007819
    FY 2022Yearly · 2022-12-31ProductServices298,585,000USD0001628280-25-007819
    FY 2022Yearly · 2022-12-31SegmentBiosecurity334,040,000USD0001628280-24-008052
    FY 2022Yearly · 2022-12-31SegmentCell Engineering143,666,000USD0001628280-24-008052
    FY 2021Yearly · 2021-12-31ProductCell Engineering Revenue112,989,000USD0001628280-24-008052
    FY 2021Yearly · 2021-12-31ProductProduct23,040,000USD0001628280-24-008052
    FY 2021Yearly · 2021-12-31ProductServices177,808,000USD0001628280-24-008052
    FY 2021Yearly · 2021-12-31SegmentBiosecurity200,848,000USD0001628280-24-008052
    FY 2021Yearly · 2021-12-31SegmentCell Engineering112,989,000USD0001628280-24-008052
    FY 2020Yearly · 2020-12-31ProductFoundry Revenue59,221,000USD0000950170-23-007461
    FY 2020Yearly · 2020-12-31ProductProduct8,707,000USD0000950170-23-007461
    FY 2020Yearly · 2020-12-31ProductServices8,729,000USD0000950170-23-007461

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.